Table 3.
Clinical outcomes of COPD exacerbation at baseline admission.
| Treatment during admission | Total admissions at baseline (n = 811) |
||
|---|---|---|---|
| Eosinophils ≥300 | Eosinophils <300 | P-value | |
| Need for supplementary O2 | 79 (74) | 579 (82) | 0.04 |
| Nebuliser treatment (Ipratropium, Salbutamol) | 102 (95) | 647 (92) | 0.2 |
| Antibiotics (oral or iv) | 69 (65) | 567 (81) | <0.001 |
| Corticosteroids (oral or iv) | 102 (95) | 639 (91) | 0.1 |
| Non-invasive ventilation | 8 (8) | 138 (20) | 0.002 |
| Treatment at intensive care unit | 5 (5) | 30 (4) | 0.07 |
| Discharged with long-term oxygen therapy* | 1 (1) | 44 (6) | 0.02 |
| Length of stay, mean in days | 2 (1–5) | 3 (1–7) | <0.001 |
| In-hospital mortality | 1 (1) | 40 (6) | 0.04 |
Data presented as number (%), median (25th-75th interquartile range), unless otherwise stated.
*Not applicable for patients who already had home oxygen or who died under index admission.